These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Intra-arterial thrombolysis in peripheral bypass and arterial occlusions. Results and predictive factors for thrombolysis]. Sandbaek G, Staxrud LE, Rosén L, Bay D, Stiris M, Gjølberg T. Tidsskr Nor Laegeforen; 1996 Oct 20; 116(25):3000-4. PubMed ID: 8975423 [Abstract] [Full Text] [Related]
29. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease. Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Wien Klin Wochenschr; 1993 Oct 20; 105(1):7-11. PubMed ID: 8438599 [Abstract] [Full Text] [Related]
35. Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy. Hess H, Mietaschk A, Brückl R. Radiology; 1987 Jun 20; 163(3):753-8. PubMed ID: 3575727 [Abstract] [Full Text] [Related]
38. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes. Cohen M. J Invasive Cardiol; 2000 Dec 20; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722 [Abstract] [Full Text] [Related]
39. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis. Vilahur G, Casaní L, Badimon L. Thromb Haemost; 2007 Sep 20; 98(3):662-9. PubMed ID: 17849057 [Abstract] [Full Text] [Related]